Table 2 microRNA differentially expressed in profiling between patient groups and controls.

From: Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus

CH and SE samples

microRNA

log2(FC)

adj p-value

miR-21-5p*

18.63

<0.001

miR-451a*

18.29

<0.001

miR-886-3p*

−5.97

<0.001

miR-9-3p

4.63

<0.001

miR-17-5p

9.9

<0.001

miR-206

5.69

<0.001

miR-92a-3p

2.08

<0.001

miR-20a-5p

6.92

<0.001

miR-204-5p*

−2.12

0.001

miR-30c-5p

−1.82

0.001

miR-331-3p

−1.61

0.006

miR-376a-3p

−2.04

0.01

miR-19b-3p*

1.52

0.017

miR-30b-5p

−1.02

0.021

miR-99b-5p

−1.19

0.034

CH and TLE samples

miR-19b-3p*

0.94

0.03

miR-204-5p*

−1.71

0.03

miR-223-3p*

1.2

0.03

miR-328-3p

0.97

0.03

miR-548a-3p

1.6

0.03

  1. Key: CH, control headache; SE, status epilepticus; TLE, temporal lobe epilepsy. log2(FC) and adjusted p-value for significantly differential expressed microRNA (OpenArray). *MicroRNA selected for validation.
Back to article page